ReviewFrontiers in clinical diabetes and healthcare2021
Making Use of Comparable Health Data to Improve Quality of Care and Outcomes in Diabetes: The EUBIROD Review of Diabetes Registries and Data Sources in Europe.
Review in Frontiers in clinical diabetes and healthcare, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The Australian Diabetes Foot Registry: From Conceptualisation to National Collaboration.International wound journal · 2026Article
- Development of a comprehensive real-world evidence dataset to inform diabetes policy: the diabetes data cell project.BMC public health · 2026Article
- Federated analytics for non-communicable disease surveillance in the European health data space: a scoping review and conceptual framework.Frontiers in public health · 2026Article
- Implementing a federated regional diabetes register in a decentralized health system: implications for healthcare organization and the European Health Data Space.Frontiers in public health · 2026Article
- Data in Diabetic Foot Care: From Current State to a Management Framework for Implementation.Journal of clinical medicine · 2025Review
- Article
- Socioeconomic disparities in diabetes prevalence among the population in Ireland.BMC public health · 2025Article
- A Composite Indicator for Primary Diabetes Care: A Cross-Sectional Study in Hungary.Healthcare (Basel, Switzerland) · 2025Article
- A taxonomy of indicators for non-communicable diseases: agreement, definition, and contextual description using diabetes as a case study.Frontiers in public health · 2025Article
- Linking registries to deliver standardized NCD indicators in the European Health Data Space: Why do we need a Collaborative Health Information European Framework (CHIEF).Frontiers in public health · 2025Article
- FAIR foundations of a novel indicator vault for non-communicable diseases in the European Union: feasibility study for effective contextualisation of indicators.Frontiers in digital health · 2025Article
- SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.European heart journal · 2023Article
- Development and operationalization of a data framework to assess quality of integrated diabetes care in the fragmented data landscape of Belgium.BMC health services research · 2022Article
- Adherence to General Diabetes and Foot Care Processes, with Prompt Referral, Are Associated with Amputation-Free Survival in People with Type 2 Diabetes and Foot Ulcers: A Scottish National Registry Analysis.Journal of diabetes research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Registries and data sources contain information that can be used on an ongoing basis to improve quality of care and outcomes of people with diabetes. As a specific task of the EU Bridge Health project, we carried out a survey of diabetes-related data sources in Europe. Objectives: We aimed to report on the organization of different sources of diabetes information, including their governance, information infrastructure and dissemination strategies for quality control, service planning, public health, policy and research. Methods: Survey using a structured questionnaire to collect targeted data from a network of collaborating institutions managing registries and data sources in 17 countries in the year 2017. Results: The 18 data sources participating in the study were most frequently academic centres (44.4%), national (72.2%), targeting all types of diabetes (61.1%) covering no more than 10% of the target population (44.4%). Although population-based in over a quarter of cases (27.8%), sources relied predominantly on provider-based datasets (38.5%), fewer using administrative data (16.6%). Data collection was continuous in the majority of cases (61.1%), but 50% could not perform data linkage. Public reports were more frequent (72.2%) as well as quality reports (77.8%), but one third did not provide feedback to policy and only half published ten or more peer reviewed papers during the last 5 years. Conclusions: The heterogeneous implementation of diabetes registries and data sources hampers the comparability of quality and outcomes across Europe. Best practices exist but need to be shared more effectively to accelerate progress and deliver equitable results for people with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.